×
Low-Dose Sertraline in the Treatment of Moderate-to-Severe Premenstrual Syndrome: Efficacy of 3 Dosing Strategies PDF
$ 40.00
Low-Dose Sertraline in the Treatment of Moderate-to-Severe Premenstrual Syndrome: Efficacy of 3 Dosing Strategies PDF quantity
$ 40.00
×
Clinical and Ethical Considerations in Pharmacogenetic Testing: Views of Physicians in 3 "Early Adopting" Departments of Psychiatry PDF
$ 40.00
Clinical and Ethical Considerations in Pharmacogenetic Testing: Views of Physicians in 3 "Early Adopting" Departments of Psychiatry PDF quantity
$ 40.00
×
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF
$ 40.00
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF quantity
$ 40.00
×
Efficacy and Safety of Loxapine in Acute Agitation: A Systematic Review of Interventional Studies PDF
$ 40.00
Efficacy and Safety of Loxapine in Acute Agitation: A Systematic Review of Interventional Studies PDF quantity
$ 40.00
×
Is Baseline Medication Resistance Associated With Potential for Relapse After Successful Remission of a Depressive Episode With ECT? Data From the Consortium for Research on Electroconvulsive Therapy (CORE) PDF
$ 40.00
Is Baseline Medication Resistance Associated With Potential for Relapse After Successful Remission of a Depressive Episode With ECT? Data From the Consortium for Research on Electroconvulsive Therapy (CORE) PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart